These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37331900)

  • 41. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.
    Zhang W; Speiser JL; Ye F; Tsai MY; Cainzos-Achirica M; Nasir K; Herrington DM; Shapiro MD
    J Am Coll Cardiol; 2021 Sep; 78(11):1083-1094. PubMed ID: 34503676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Hiramoto JS; Katz R; Peralta CA; Ix JH; Fried L; Cushman M; Siscovick D; Palmas W; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Aug; 60(2):225-32. PubMed ID: 22560844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study.
    Akinyelure OP; Colantonio LD; Chaudhary NS; Jaeger BC; Judd SE; Cushman M; Zakai NA; Kabagambe EK; Howard VJ; Safford MM; Irvin MR
    Am Heart J; 2022 Nov; 253():39-47. PubMed ID: 35810789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
    Bluemke DA; Kronmal RA; Lima JA; Liu K; Olson J; Burke GL; Folsom AR
    J Am Coll Cardiol; 2008 Dec; 52(25):2148-55. PubMed ID: 19095132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis.
    Yeboah J; McNamara C; Jiang XC; Tabas I; Herrington DM; Burke GL; Shea S
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):628-33. PubMed ID: 20032291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study.
    Arima H; Kubo M; Yonemoto K; Doi Y; Ninomiya T; Tanizaki Y; Hata J; Matsumura K; Iida M; Kiyohara Y
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1385-91. PubMed ID: 18403728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study.
    Arafa A; Kashima R; Yasui Y; Kawachi H; Matsumoto C; Nosaka S; Teramoto M; Matsuo M; Kokubo Y
    Environ Health Prev Med; 2023; 28():61. PubMed ID: 37899208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.
    Arnold N; Blaum C; Goßling A; Brunner FJ; Bay B; Ferrario MM; Brambilla P; Cesana G; Leoni V; Palmieri L; Donfrancesco C; Padró T; Andersson J; Jousilahti P; Ojeda F; Zeller T; Linneberg A; Söderberg S; Iacoviello L; Gianfagna F; Sans S; Veronesi G; Thorand B; Peters A; Tunstall-Pedoe H; Kee F; Salomaa V; Schnabel RB; Kuulasmaa K; Blankenberg S; Koenig W; Waldeyer C
    Eur Heart J; 2024 Mar; 45(12):1043-1054. PubMed ID: 38240386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
    ; Erqou S; Kaptoge S; Perry PL; Di Angelantonio E; Thompson A; White IR; Marcovina SM; Collins R; Thompson SG; Danesh J
    JAMA; 2009 Jul; 302(4):412-23. PubMed ID: 19622820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT).
    Appiah LT; Sarfo FS; Nguah SB; Huffman MD; Stiles JK; Feinstein MJ
    Glob Heart; 2020 Nov; 15(1):74. PubMed ID: 33299770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults.
    Rodondi N; Marques-Vidal P; Butler J; Sutton-Tyrrell K; Cornuz J; Satterfield S; Harris T; Bauer DC; Ferrucci L; Vittinghoff E; Newman AB;
    Am J Epidemiol; 2010 Mar; 171(5):540-9. PubMed ID: 20110287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-reactive Protein Level, Apolipoprotein B-to-apolipoprotein A-1 Ratio, and Risks of Ischemic Stroke and Coronary Heart Disease among Inner Mongolians in China.
    Tian YF; Zhou YP; Zhong CK; Buren B; Xu T; Li HM; Zhang MZ; Wang AL; Zhang YH
    Biomed Environ Sci; 2016 Jul; 29(7):467-74. PubMed ID: 27554116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.
    Dai W; Li Y; Lv YN; Wei CD; Zheng HY
    Atherosclerosis; 2014 Apr; 233(2):661-665. PubMed ID: 24561551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.
    Guan W; Cao J; Steffen BT; Post WS; Stein JH; Tattersall MC; Kaufman JD; McConnell JP; Hoefner DM; Warnick R; Tsai MY
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):996-1001. PubMed ID: 25810300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.
    Evensen LH; Folsom AR; Pankow JS; Hansen JB; Allison MA; Cushman M; Lutsey PL
    J Thromb Haemost; 2021 Jul; 19(7):1718-1728. PubMed ID: 33773045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.
    Hyacinth HI; Franceschini N; Seals SR; Irvin MR; Chaudhary N; Naik RP; Alonso A; Carty CL; Burke GL; Zakai NA; Winkler CA; David VA; Kopp JB; Judd SE; Adams RJ; Gee BE; Longstreth WT; Egede L; Lackland DT; Greenberg CS; Taylor H; Manson JE; Key NS; Derebail VK; Kshirsagar AV; Folsom AR; Konety SH; Howard V; Allison M; Wilson JG; Correa A; Zhi D; Arnett DK; Howard G; Reiner AP; Cushman M; Safford MM
    JAMA Netw Open; 2021 Jan; 4(1):e2030435. PubMed ID: 33399855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion.
    Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J
    Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.